Skip to Main Content

Paper Details

Economic burden of renal cell carcinoma: Part I--an updated review.
PharmacoEconomics
21
2011
RCC, bevacizumab, metastatic RCC, patient, renal cell carcinoma, sorafenib, sunitinib, temsirolimus

Datasets